Physician profile
Tiffany Bee
NPI 1811953607
$620.44
in general payments reported to CMS, 2019-2025
10 companies · $22.86 in 2025
The $22.86 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $33.82 · 2022: $108 · 2023: $93.73 · 2024: $20.00 · 2025: $22.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.59 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $292.42 | 2019 | |
| Prytime Medical Devices, INC. | $107.89 | 2022 | |
| Stryker Corporation | $56.59 | 2023 | Actishield Cf |
| Cerus Corporation | $37.14 | 2023 | Intercept Blood System For Platelets |
| Boston Scientific Corporation | $26.10 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $23.62 | 2019 | |
| Zimmer Biomet Holdings, INC. | $22.86 | 2025 | Ribfix Titan |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Cook Medical LLC | $18.89 | 2020 | |
| Covidien LP | $14.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Bee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.